Ann: OLE Study update reveals impressive Survival Data, page-229

I'm not sure if you're saying you expect 50% of OLE Study patients to have passed by the time of the next report, or if you mean, as I thought MT meant, that until we get to the 50% mark of patients passing away, then any survivability data up until then is good news. I expect that every day we have OLE Study patients defying death, they are continually demonstrating improved statistically significant survival rates. Yes the group is small, but as Berry have already ascertained and presented, the survival rates at end of Phase 1 were already remarkable. The remarkability continues to grow with each month we have patients surviving longer with the help of MPL. Once we get to the point of 50% of OLE patients passing (which eventually will happen - MPL is a treatment, not a cure), then the OLE Study stops a such (but I imagine compassionate use will continue once again).